Table of Content

1 Human Recombinant Insulin Market Overview
1.1 Product Overview and Scope of Human Recombinant Insulin
1.2 Human Recombinant Insulin Segment by Type
1.2.1 Global Human Recombinant Insulin Market Value Comparison by Type (2024-2034)
1.2.2 Rapid-Acting Human Insulin
1.2.3 Regular (Short Acting) Insulin
1.2.4 NPH (Intermediate Acting) Insulin
1.2.5 Long-Acting Human Insulin
1.2.6 Premixed Human Insulins Insulin
1.3 Human Recombinant Insulin Segment by Application
1.3.1 Global Human Recombinant Insulin Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Global Human Recombinant Insulin Market Size Estimates and Forecasts
1.4.1 Global Human Recombinant Insulin Revenue 2018-2034
1.4.2 Global Human Recombinant Insulin Sales 2018-2034
1.4.3 Global Human Recombinant Insulin Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Human Recombinant Insulin Market Competition by Manufacturers
2.1 Global Human Recombinant Insulin Sales Market Share by Manufacturers (2018-2024)
2.2 Global Human Recombinant Insulin Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Human Recombinant Insulin Average Price by Manufacturers (2018-2024)
2.4 Global Human Recombinant Insulin Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Human Recombinant Insulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Recombinant Insulin, Product Type & Application
2.7 Human Recombinant Insulin Market Competitive Situation and Trends
2.7.1 Human Recombinant Insulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Recombinant Insulin Players Market Share by Revenue
2.7.3 Global Human Recombinant Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Recombinant Insulin Retrospective Market Scenario by Region
3.1 Global Human Recombinant Insulin Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Human Recombinant Insulin Global Human Recombinant Insulin Sales by Region: 2018-2034
3.2.1 Global Human Recombinant Insulin Sales by Region: 2018-2024
3.2.2 Global Human Recombinant Insulin Sales by Region: 2024-2034
3.3 Global Human Recombinant Insulin Global Human Recombinant Insulin Revenue by Region: 2018-2034
3.3.1 Global Human Recombinant Insulin Revenue by Region: 2018-2024
3.3.2 Global Human Recombinant Insulin Revenue by Region: 2024-2034
3.4 North America Human Recombinant Insulin Market Facts & Figures by Country
3.4.1 North America Human Recombinant Insulin Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Human Recombinant Insulin Sales by Country (2018-2034)
3.4.3 North America Human Recombinant Insulin Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Recombinant Insulin Market Facts & Figures by Country
3.5.1 Europe Human Recombinant Insulin Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Human Recombinant Insulin Sales by Country (2018-2034)
3.5.3 Europe Human Recombinant Insulin Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Recombinant Insulin Market Facts & Figures by Country
3.6.1 Asia Pacific Human Recombinant Insulin Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Human Recombinant Insulin Sales by Country (2018-2034)
3.6.3 Asia Pacific Human Recombinant Insulin Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Recombinant Insulin Market Facts & Figures by Country
3.7.1 Latin America Human Recombinant Insulin Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Human Recombinant Insulin Sales by Country (2018-2034)
3.7.3 Latin America Human Recombinant Insulin Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Recombinant Insulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Recombinant Insulin Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Human Recombinant Insulin Sales by Country (2018-2034)
3.8.3 Middle East and Africa Human Recombinant Insulin Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Recombinant Insulin Sales by Type (2018-2034)
4.1.1 Global Human Recombinant Insulin Sales by Type (2018-2024)
4.1.2 Global Human Recombinant Insulin Sales by Type (2024-2034)
4.1.3 Global Human Recombinant Insulin Sales Market Share by Type (2018-2034)
4.2 Global Human Recombinant Insulin Revenue by Type (2018-2034)
4.2.1 Global Human Recombinant Insulin Revenue by Type (2018-2024)
4.2.2 Global Human Recombinant Insulin Revenue by Type (2024-2034)
4.2.3 Global Human Recombinant Insulin Revenue Market Share by Type (2018-2034)
4.3 Global Human Recombinant Insulin Price by Type (2018-2034)
5 Segment by Application
5.1 Global Human Recombinant Insulin Sales by Application (2018-2034)
5.1.1 Global Human Recombinant Insulin Sales by Application (2018-2024)
5.1.2 Global Human Recombinant Insulin Sales by Application (2024-2034)
5.1.3 Global Human Recombinant Insulin Sales Market Share by Application (2018-2034)
5.2 Global Human Recombinant Insulin Revenue by Application (2018-2034)
5.2.1 Global Human Recombinant Insulin Revenue by Application (2018-2024)
5.2.2 Global Human Recombinant Insulin Revenue by Application (2024-2034)
5.2.3 Global Human Recombinant Insulin Revenue Market Share by Application (2018-2034)
5.3 Global Human Recombinant Insulin Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Human Recombinant Insulin Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Novo Nordisk Human Recombinant Insulin Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly and Company
6.2.1 Eli Lilly and Company Corporation Information
6.2.2 Eli Lilly and Company Description and Business Overview
6.2.3 Eli Lilly and Company Human Recombinant Insulin Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Eli Lilly and Company Human Recombinant Insulin Product Portfolio
6.2.5 Eli Lilly and Company Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Human Recombinant Insulin Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Sanofi Human Recombinant Insulin Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Julphar Gulf Pharmaceutical Industries
6.4.1 Julphar Gulf Pharmaceutical Industries Corporation Information
6.4.2 Julphar Gulf Pharmaceutical Industries Description and Business Overview
6.4.3 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Product Portfolio
6.4.5 Julphar Gulf Pharmaceutical Industries Recent Developments/Updates
6.5 Bioton
6.5.1 Bioton Corporation Information
6.5.2 Bioton Description and Business Overview
6.5.3 Bioton Human Recombinant Insulin Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Bioton Human Recombinant Insulin Product Portfolio
6.5.5 Bioton Recent Developments/Updates
6.6 Gan & Lee Pharmaceuticals
6.6.1 Gan & Lee Pharmaceuticals Corporation Information
6.6.2 Gan & Lee Pharmaceuticals Description and Business Overview
6.6.3 Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Gan & Lee Pharmaceuticals Human Recombinant Insulin Product Portfolio
6.6.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
6.7 Zhuhai United Laboratories
6.6.1 Zhuhai United Laboratories Corporation Information
6.6.2 Zhuhai United Laboratories Description and Business Overview
6.6.3 Zhuhai United Laboratories Human Recombinant Insulin Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Zhuhai United Laboratories Human Recombinant Insulin Product Portfolio
6.7.5 Zhuhai United Laboratories Recent Developments/Updates
6.8 Biocon
6.8.1 Biocon Corporation Information
6.8.2 Biocon Description and Business Overview
6.8.3 Biocon Human Recombinant Insulin Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Biocon Human Recombinant Insulin Product Portfolio
6.8.5 Biocon Recent Developments/Updates
6.9 Wanbang Biopharmaceuticals
6.9.1 Wanbang Biopharmaceuticals Corporation Information
6.9.2 Wanbang Biopharmaceuticals Description and Business Overview
6.9.3 Wanbang Biopharmaceuticals Human Recombinant Insulin Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Wanbang Biopharmaceuticals Human Recombinant Insulin Product Portfolio
6.9.5 Wanbang Biopharmaceuticals Recent Developments/Updates
6.10 Dongbao Enterprise Group
6.10.1 Dongbao Enterprise Group Corporation Information
6.10.2 Dongbao Enterprise Group Description and Business Overview
6.10.3 Dongbao Enterprise Group Human Recombinant Insulin Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Dongbao Enterprise Group Human Recombinant Insulin Product Portfolio
6.10.5 Dongbao Enterprise Group Recent Developments/Updates
6.11 PeproTech
6.11.1 PeproTech Corporation Information
6.11.2 PeproTech Human Recombinant Insulin Description and Business Overview
6.11.3 PeproTech Human Recombinant Insulin Sales, Revenue and Gross Margin (2018-2024)
6.11.4 PeproTech Human Recombinant Insulin Product Portfolio
6.11.5 PeproTech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Recombinant Insulin Industry Chain Analysis
7.2 Human Recombinant Insulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Recombinant Insulin Production Mode & Process
7.4 Human Recombinant Insulin Sales and Marketing
7.4.1 Human Recombinant Insulin Sales Channels
7.4.2 Human Recombinant Insulin Distributors
7.5 Human Recombinant Insulin Customers
8 Human Recombinant Insulin Market Dynamics
8.1 Human Recombinant Insulin Industry Trends
8.2 Human Recombinant Insulin Market Drivers
8.3 Human Recombinant Insulin Market Challenges
8.4 Human Recombinant Insulin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Recombinant Insulin Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Human Recombinant Insulin Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Human Recombinant Insulin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Recombinant Insulin Sales (K Litre) of Key Manufacturers (2018-2024)
Table 5. Global Human Recombinant Insulin Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Human Recombinant Insulin Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Human Recombinant Insulin Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Human Recombinant Insulin Average Price (USD/Litre) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Human Recombinant Insulin, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Human Recombinant Insulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Recombinant Insulin, Product Type & Application
Table 12. Global Key Manufacturers of Human Recombinant Insulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Recombinant Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Recombinant Insulin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Recombinant Insulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Human Recombinant Insulin Sales by Region (2018-2024) & (K Litre)
Table 18. Global Human Recombinant Insulin Sales Market Share by Region (2018-2024)
Table 19. Global Human Recombinant Insulin Sales by Region (2024-2034) & (K Litre)
Table 20. Global Human Recombinant Insulin Sales Market Share by Region (2024-2034)
Table 21. Global Human Recombinant Insulin Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Human Recombinant Insulin Revenue Market Share by Region (2018-2024)
Table 23. Global Human Recombinant Insulin Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Human Recombinant Insulin Revenue Market Share by Region (2024-2034)
Table 25. North America Human Recombinant Insulin Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Human Recombinant Insulin Sales by Country (2018-2024) & (K Litre)
Table 27. North America Human Recombinant Insulin Sales by Country (2024-2034) & (K Litre)
Table 28. North America Human Recombinant Insulin Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Human Recombinant Insulin Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Human Recombinant Insulin Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Human Recombinant Insulin Sales by Country (2018-2024) & (K Litre)
Table 32. Europe Human Recombinant Insulin Sales by Country (2024-2034) & (K Litre)
Table 33. Europe Human Recombinant Insulin Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Human Recombinant Insulin Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Human Recombinant Insulin Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Human Recombinant Insulin Sales by Region (2018-2024) & (K Litre)
Table 37. Asia Pacific Human Recombinant Insulin Sales by Region (2024-2034) & (K Litre)
Table 38. Asia Pacific Human Recombinant Insulin Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Human Recombinant Insulin Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Human Recombinant Insulin Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Human Recombinant Insulin Sales by Country (2018-2024) & (K Litre)
Table 42. Latin America Human Recombinant Insulin Sales by Country (2024-2034) & (K Litre)
Table 43. Latin America Human Recombinant Insulin Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Human Recombinant Insulin Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Human Recombinant Insulin Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Human Recombinant Insulin Sales by Country (2018-2024) & (K Litre)
Table 47. Middle East & Africa Human Recombinant Insulin Sales by Country (2024-2034) & (K Litre)
Table 48. Middle East & Africa Human Recombinant Insulin Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Human Recombinant Insulin Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Human Recombinant Insulin Sales (K Litre) by Type (2018-2024)
Table 51. Global Human Recombinant Insulin Sales (K Litre) by Type (2024-2034)
Table 52. Global Human Recombinant Insulin Sales Market Share by Type (2018-2024)
Table 53. Global Human Recombinant Insulin Sales Market Share by Type (2024-2034)
Table 54. Global Human Recombinant Insulin Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Human Recombinant Insulin Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Human Recombinant Insulin Revenue Market Share by Type (2018-2024)
Table 57. Global Human Recombinant Insulin Revenue Market Share by Type (2024-2034)
Table 58. Global Human Recombinant Insulin Price (USD/Litre) by Type (2018-2024)
Table 59. Global Human Recombinant Insulin Price (USD/Litre) by Type (2024-2034)
Table 60. Global Human Recombinant Insulin Sales (K Litre) by Application (2018-2024)
Table 61. Global Human Recombinant Insulin Sales (K Litre) by Application (2024-2034)
Table 62. Global Human Recombinant Insulin Sales Market Share by Application (2018-2024)
Table 63. Global Human Recombinant Insulin Sales Market Share by Application (2024-2034)
Table 64. Global Human Recombinant Insulin Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Human Recombinant Insulin Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Human Recombinant Insulin Revenue Market Share by Application (2018-2024)
Table 67. Global Human Recombinant Insulin Revenue Market Share by Application (2024-2034)
Table 68. Global Human Recombinant Insulin Price (USD/Litre) by Application (2018-2024)
Table 69. Global Human Recombinant Insulin Price (USD/Litre) by Application (2024-2034)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2018-2024)
Table 73. Novo Nordisk Human Recombinant Insulin Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Eli Lilly and Company Corporation Information
Table 76. Eli Lilly and Company Description and Business Overview
Table 77. Eli Lilly and Company Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2018-2024)
Table 78. Eli Lilly and Company Human Recombinant Insulin Product
Table 79. Eli Lilly and Company Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2018-2024)
Table 83. Sanofi Human Recombinant Insulin Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Julphar Gulf Pharmaceutical Industries Corporation Information
Table 86. Julphar Gulf Pharmaceutical Industries Description and Business Overview
Table 87. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2018-2024)
Table 88. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Product
Table 89. Julphar Gulf Pharmaceutical Industries Recent Developments/Updates
Table 90. Bioton Corporation Information
Table 91. Bioton Description and Business Overview
Table 92. Bioton Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2018-2024)
Table 93. Bioton Human Recombinant Insulin Product
Table 94. Bioton Recent Developments/Updates
Table 95. Gan & Lee Pharmaceuticals Corporation Information
Table 96. Gan & Lee Pharmaceuticals Description and Business Overview
Table 97. Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2018-2024)
Table 98. Gan & Lee Pharmaceuticals Human Recombinant Insulin Product
Table 99. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 100. Zhuhai United Laboratories Corporation Information
Table 101. Zhuhai United Laboratories Description and Business Overview
Table 102. Zhuhai United Laboratories Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2018-2024)
Table 103. Zhuhai United Laboratories Human Recombinant Insulin Product
Table 104. Zhuhai United Laboratories Recent Developments/Updates
Table 105. Biocon Corporation Information
Table 106. Biocon Description and Business Overview
Table 107. Biocon Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2018-2024)
Table 108. Biocon Human Recombinant Insulin Product
Table 109. Biocon Recent Developments/Updates
Table 110. Wanbang Biopharmaceuticals Corporation Information
Table 111. Wanbang Biopharmaceuticals Description and Business Overview
Table 112. Wanbang Biopharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2018-2024)
Table 113. Wanbang Biopharmaceuticals Human Recombinant Insulin Product
Table 114. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 115. Dongbao Enterprise Group Corporation Information
Table 116. Dongbao Enterprise Group Description and Business Overview
Table 117. Dongbao Enterprise Group Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2018-2024)
Table 118. Dongbao Enterprise Group Human Recombinant Insulin Product
Table 119. Dongbao Enterprise Group Recent Developments/Updates
Table 120. PeproTech Corporation Information
Table 121. PeproTech Description and Business Overview
Table 122. PeproTech Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2018-2024)
Table 123. PeproTech Human Recombinant Insulin Product
Table 124. PeproTech Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Human Recombinant Insulin Distributors List
Table 128. Human Recombinant Insulin Customers List
Table 129. Human Recombinant Insulin Market Trends
Table 130. Human Recombinant Insulin Market Drivers
Table 131. Human Recombinant Insulin Market Challenges
Table 132. Human Recombinant Insulin Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Recombinant Insulin
Figure 2. Global Human Recombinant Insulin Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Human Recombinant Insulin Market Share by Type in 2022 & 2034
Figure 4. Rapid-Acting Human Insulin Product Picture
Figure 5. Regular (Short Acting) Insulin Product Picture
Figure 6. NPH (Intermediate Acting) Insulin Product Picture
Figure 7. Long-Acting Human Insulin Product Picture
Figure 8. Premixed Human Insulins Insulin Product Picture
Figure 9. Global Human Recombinant Insulin Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Human Recombinant Insulin Market Share by Application in 2022 & 2034
Figure 11. Hospital
Figure 12. Retail Pharmacy
Figure 13. Online Pharmacies
Figure 14. Other
Figure 15. Global Human Recombinant Insulin Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Human Recombinant Insulin Market Size (2018-2034) & (US$ Million)
Figure 17. Global Human Recombinant Insulin Sales (2018-2034) & (K Litre)
Figure 18. Global Human Recombinant Insulin Average Price (USD/Litre) & (2018-2034)
Figure 19. Human Recombinant Insulin Report Years Considered
Figure 20. Human Recombinant Insulin Sales Share by Manufacturers in 2022
Figure 21. Global Human Recombinant Insulin Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Human Recombinant Insulin Players: Market Share by Revenue in 2022
Figure 23. Human Recombinant Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Human Recombinant Insulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 25. North America Human Recombinant Insulin Sales Market Share by Country (2018-2034)
Figure 26. North America Human Recombinant Insulin Revenue Market Share by Country (2018-2034)
Figure 27. U.S. Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Canada Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Europe Human Recombinant Insulin Sales Market Share by Country (2018-2034)
Figure 30. Europe Human Recombinant Insulin Revenue Market Share by Country (2018-2034)
Figure 31. Germany Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. France Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. U.K. Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Italy Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Russia Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Asia Pacific Human Recombinant Insulin Sales Market Share by Region (2018-2034)
Figure 37. Asia Pacific Human Recombinant Insulin Revenue Market Share by Region (2018-2034)
Figure 38. China Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Japan Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. South Korea Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. India Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Australia Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Taiwan Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Indonesia Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Thailand Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Malaysia Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Philippines Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Latin America Human Recombinant Insulin Sales Market Share by Country (2018-2034)
Figure 49. Latin America Human Recombinant Insulin Revenue Market Share by Country (2018-2034)
Figure 50. Mexico Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Brazil Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Argentina Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Middle East & Africa Human Recombinant Insulin Sales Market Share by Country (2018-2034)
Figure 54. Middle East & Africa Human Recombinant Insulin Revenue Market Share by Country (2018-2034)
Figure 55. Turkey Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Saudi Arabia Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. UAE Human Recombinant Insulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Global Sales Market Share of Human Recombinant Insulin by Type (2018-2034)
Figure 59. Global Revenue Market Share of Human Recombinant Insulin by Type (2018-2034)
Figure 60. Global Human Recombinant Insulin Price (USD/Litre) by Type (2018-2034)
Figure 61. Global Sales Market Share of Human Recombinant Insulin by Application (2018-2034)
Figure 62. Global Revenue Market Share of Human Recombinant Insulin by Application (2018-2034)
Figure 63. Global Human Recombinant Insulin Price (USD/Litre) by Application (2018-2034)
Figure 64. Human Recombinant Insulin Value Chain
Figure 65. Human Recombinant Insulin Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed